English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

BACKGROUND: In Brazil, the prophylaxis of influenza with the antivirals oseltamivir and zanamivir is cost-effective and recommended for the groups with higher risk of complications. In this study we estimated the impact of the chemoprophylaxis in the health system budget from 2017 to 2023. METHODS: We calculated the size of the risk population, expenditure with prophylaxis and the budget impact in 2017 to 2018 with official demographic and vaccine coverage data, and aqcuisition of antivirals by SUS. The estimative from 2019 to 2023 was conducted using trigonometric models. RESULTS AND CONCLUSION: The risk population variated from 2.3 to 5.5 millions of individuals and the budget impact variated from 0.74% (2018) and 6.9% (2019).

Chemoprophylaxis of Influenza A (H1N1) in the perspective of the Brazilian Unified Health System (SUS): a budget impact analysis